Matched unrelated donor HSCT for thalassemia major using treosulphan based conditioning protocol for children: A single center experience from India

• 主要な著者: Khushnuma Mullanfiroze (著者), Ramya Uppuluri (著者), Divya Subburaj (著者), Dhaarani Jayaraman (著者), V.S. Venkateswaran (著者), Revathi Raj (著者), V. Lakshman (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2017-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment for patients with thalassemia major. However, only 30-35% of patients have a suitable HLA-matched family donor (MFD). We report herewith our experience with matched unrelated donor (MUD) HSCT using a treosulfan...